Company / Working Capital per Share
SUTRO BIOPHARMA, INC. Working Capital per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$9.12
FY2025
5-year range
$3.47 / $9.12
FY2021-FY2025
Trend
+163.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share returned to growth in FY2025 after 2 years of decline, reaching $9.12.
Based on SEC 10-K filings.
9.12 in FY2025 with a 5-year CAGR of -9.6%.
Improved from $5.70 to $9.12 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +13.8%
- 5-Year CAGR
- -9.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share increased 163.3% year-over-year.
- Peak working capital per share was recorded in FY2018.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.12 | +163.3% |
| FY2024 | $3.47 | -39.2% |
| FY2023 | $5.70 | -7.9% |
| FY2022 | $6.19 | +60.1% |
| FY2021 | $3.86 | -74.4% |
| FY2020 | $15.09 | +260.7% |
| FY2019 | $4.18 | -98.9% |
| FY2018 | $372.90 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026